Matches in Wikidata for { <http://www.wikidata.org/entity/Q80442363> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q80442363 description "artículu científicu espublizáu en payares de 2007" @default.
- Q80442363 description "im November 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80442363 description "scientific article published on 01 November 2007" @default.
- Q80442363 description "wetenschappelijk artikel" @default.
- Q80442363 description "наукова стаття, опублікована в листопаді 2007" @default.
- Q80442363 name "Anti-cyclic citrullinated peptide antibodies (CCP2) in patients with psoriatic arthritis" @default.
- Q80442363 name "Anti-cyclic citrullinated peptide antibodies (CCP2) in patients with psoriatic arthritis" @default.
- Q80442363 type Item @default.
- Q80442363 label "Anti-cyclic citrullinated peptide antibodies (CCP2) in patients with psoriatic arthritis" @default.
- Q80442363 label "Anti-cyclic citrullinated peptide antibodies (CCP2) in patients with psoriatic arthritis" @default.
- Q80442363 prefLabel "Anti-cyclic citrullinated peptide antibodies (CCP2) in patients with psoriatic arthritis" @default.
- Q80442363 prefLabel "Anti-cyclic citrullinated peptide antibodies (CCP2) in patients with psoriatic arthritis" @default.
- Q80442363 P1433 Q80442363-5746A1F3-3997-4419-B8CA-E2EBBFC033F8 @default.
- Q80442363 P1476 Q80442363-21F4D9ED-1384-443A-BF58-DF8AE18B5F27 @default.
- Q80442363 P2093 Q80442363-1A18903B-BAD1-40A0-8DC8-CBB1DF2C9F4E @default.
- Q80442363 P2093 Q80442363-1DEA5655-D615-4917-8CA4-C39302E25859 @default.
- Q80442363 P2093 Q80442363-505122FA-C371-4916-BA61-79E1B295126E @default.
- Q80442363 P2093 Q80442363-53BB1C09-F6D7-4B24-9D9E-634F38467EC7 @default.
- Q80442363 P2093 Q80442363-7CA96D6A-6CCC-442D-83BD-53DBE7A6B7E4 @default.
- Q80442363 P2093 Q80442363-A492F935-0E16-4879-B25C-E4FE98205F67 @default.
- Q80442363 P2093 Q80442363-F78A2904-8767-487C-8748-28EB696A9F46 @default.
- Q80442363 P304 Q80442363-936DC4D9-9FF1-4412-A299-8F7E04A53C56 @default.
- Q80442363 P31 Q80442363-A94D7791-41B9-4AA2-B626-2C667B2B0AFF @default.
- Q80442363 P433 Q80442363-BEE421A2-8F77-496D-B885-3346AA28B6B3 @default.
- Q80442363 P478 Q80442363-55C924BE-2CF0-40BF-B5CE-6D949D15BD6E @default.
- Q80442363 P577 Q80442363-116F7E07-3F9E-4D08-B80E-8CA5A06C569A @default.
- Q80442363 P698 Q80442363-1D5EE5C4-E1C5-4CC6-920D-C96913BA33DC @default.
- Q80442363 P921 Q80442363-83C260A8-11E6-4983-8FEE-E74132B22AA5 @default.
- Q80442363 P698 18173933 @default.
- Q80442363 P1433 Q15759225 @default.
- Q80442363 P1476 "Anti-cyclic citrullinated peptide antibodies (CCP2) in patients with psoriatic arthritis" @default.
- Q80442363 P2093 "D-D Ouédraogo" @default.
- Q80442363 P2093 "E Palazzo" @default.
- Q80442363 P2093 "G Hayem" @default.
- Q80442363 P2093 "N Somogyi" @default.
- Q80442363 P2093 "O Meyer" @default.
- Q80442363 P2093 "P Nicaise-Roland" @default.
- Q80442363 P2093 "S Grootenboer-Mignot" @default.
- Q80442363 P304 "930-931" @default.
- Q80442363 P31 Q13442814 @default.
- Q80442363 P433 "6" @default.
- Q80442363 P478 "25" @default.
- Q80442363 P577 "2007-11-01T00:00:00Z" @default.
- Q80442363 P698 "18173933" @default.
- Q80442363 P921 Q511097 @default.